The Drug Enforcement Administration is signaling that it will extend flexibilities, enacted during the COVID-19 pandemic, that allows healthcare providers to prescribe specific controlled substances via telehealth, Politico reported Oct. 11.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
